Golotimod TFA

Description

Golotimod TFA SCV 07 TFA , an immunomodulating peptide with antimicrobial activity, significantly increases the efficacy of antituberculosis therapy, stimulates thymic and splenic cell proliferation, and improves macrophage function. Golotimod TFA SCV 07 TFA inhibits STAT3 signaling and modulates the duration and severity of oral mucositis in animal models that received radiation or a combination of radiation and Cisplatin. Golotimod TFA SCV 07 TFA is also a potential therapeutic for recurrent genital herpes simplex virus type 2 HSV-2 .